Tech Company Financing Transactions
Anza Therapeutics Funding Round
Anza Therapeutics, operating out of Concord, secured $18 million in funding from Sofinnova Ventures and Versant Ventures.
Transaction Overview
Company Name
Announced On
12/31/2007
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Cook
Browse more venture capital transactions:
Prev: 12/31/2007: Linkage Biosciences venture capital transaction
Next: 12/31/2007: E Ink venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs